Drug maker Lupin saw its consolidated profits for the quarter ended March 31 rise 64.16 percent to Rs.157.3 crore, as against Rs.95.87 crore for the corresponding period last year, the company said Wednesday.2:30 PM on May 14
Be the first to comment...
Add Your Comment